Latest Articles

Publication Date
Squamous Cell Carcinoma of the Ovary: A Rare Case.

Ovarian squamous cell carcinoma (SCC) is a rare entity among primary ovarian cancers. This type of cancer typically originates from the transformation of mature cystic teratomas, commonly known as dermoid …

Published: Nov. 26, 2024, midnight
The gut-reproductive axis: Bridging microbiota balances to reproductive health and fetal development.

The gut microbiota is a highly complex microbial community residing in the digestive tract of humans and animals, closely linked to host health. Dysbiosis within the gut microbiota has been …

Published: Nov. 22, 2024, midnight
Research targets DNA repair vulnerabilities in female reproductive cancers - Medical Xpress

Research targets DNA repair vulnerabilities in female reproductive cancers Medical Xpress

Published: Nov. 18, 2024, 4:47 p.m.
Researcher Targets DNA Repair Vulnerabilities in Female Reproductive Cancers - Tufts Now

Researcher Targets DNA Repair Vulnerabilities in Female Reproductive Cancers Tufts Now

Published: Nov. 15, 2024, noon
Microbial harmony in female reproductive health: exploring the impact of intestinal flora on ovarian function and disease pathogenesis.

The intestinal microbiota is vast in type and quantity and it plays a critical role in regulating various physiological functions in the host, including intestinal function, immune response and energy …

Published: Nov. 15, 2024, midnight
Sacituzumab Tirumotecan Shows Antitumor Activity in Previously Treated Endometrial, Ovarian Cancers - OncLive

Sacituzumab Tirumotecan Shows Antitumor Activity in Previously Treated Endometrial, Ovarian Cancers OncLive

Published: Nov. 14, 2024, 8:14 p.m.
Signs of three cancers can appear in your face and shouldn't be ignored, health experts say - Chronicle Live

Signs of three cancers can appear in your face and shouldn't be ignored, health experts say Chronicle Live

Published: Nov. 12, 2024, 2:26 p.m.
Merck’s KEYTRUDA® (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers - BioSpace

Merck’s KEYTRUDA® (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers BioSpace

Published: Oct. 24, 2024, 11:46 a.m.
Approval From European Commission With Two New Indications in Gynecologic Cancers - businesswire.com

Approval From European Commission With Two New Indications in Gynecologic Cancers businesswire.com

Published: Oct. 24, 2024, 10:45 a.m.
Factors in malignant transformation of ovarian endometriosis: A narrative review.

Endometriosis is a common estrogen-dependent inflammatory disease with a chronic course and a tendency to recur. The association between endometriosis and cancer has been studied for several years. Numerous reports …

Published: Oct. 24, 2024, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!